S-4 (Andarine)
Shop S-4 (Andarine) on KimeraChems · code GUIDE (10% off)Definition
S-4, commonly referred to as Andarine, is an investigational selective androgen receptor modulator (SARM) studied in laboratory settings for its androgen receptor (AR) activity, particularly in skeletal muscle- and body-composition-focused research models. SARMs are designed to preferentially activate androgen receptor signaling in selected tissues compared with traditional anabolic steroids, although observed tissue selectivity depends on the experimental model, dose, and duration of exposure. S-4 is not approved for human or veterinary use and is supplied strictly for laboratory and analytical research purposes.
Mechanism of Action
S-4 is studied as a selective androgen receptor agonist with partial agonist characteristics in certain experimental systems. Androgen receptor activation influences transcriptional programs involved in muscle protein balance, tissue remodeling, and metabolic regulation. Common areas of mechanistic investigation include
- Androgen receptor activation: Studied for its ability to bind the androgen receptor and regulate androgen-responsive gene transcription
- Anabolic signaling: Investigated for activation of pathways associated with skeletal-muscle maintenance and protein synthesis
- Tissue selectivity: Explored for differential androgen receptor activity across tissues under varying exposure conditions
- Dose-dependent pharmacology: Studied for potential tradeoffs between intended tissue-selective signaling and broader androgenic effects as exposure increases
- Endocrine regulation: Longer-duration in vivo studies commonly monitor downstream endocrine biomarkers during sustained androgen receptor activation
Areas of Investigation
S-4 is commonly studied in
- Lean-mass preservation during caloric restriction or catabolic stress
- Body-composition research in controlled experimental models
- Androgen receptor pharmacology and tissue-selectivity comparisons among SARMs
- Endocrine feedback and recovery following discontinuation
- Tissue-specific androgen receptor signaling across skeletal muscle, bone, and androgen-sensitive tissues
Safety Profile
Reported observations are model- and exposure-dependent and may include
- Suppression-like findings involving endogenous gonadotropin biomarkers in certain in vivo models
- Alterations in lipid biomarkers and hepatic-enzyme measurements depending on exposure level and study duration
- Androgenic findings in non-target tissues when tissue selectivity is exceeded
- Visual disturbances discussed in anecdotal reports and nonclinical literature, including altered night vision and yellow-tinted color perception, representing a distinguishing feature frequently associated with S-4
- Rebound changes in endocrine biomarkers following discontinuation in some experimental models
Interaction Notes
S-4 is often explored alongside interventions that overlap with androgenic and anabolic signaling.
For educational purposes only. Not for human consumption.